Top Markets
Coin of the day
Miravant Medical Technologies Inc. Miravant Medical Technologies Inc.

Miravant Medical Technologies Inc.

MRVT
株式のランク #42699
Miravant Medical Technologies Inc. operates as a specialized firm dedicated to... Miravant Medical Technologies Inc. operates as a specialized firm dedicated to pharmaceutical research and development. A cornerstone of its work involves PhotoPoint, an innovative photodynamic therapy designed to eradicate cancerous cells when exposed to light. Furthermore, the company manufactures the essential light-generating and light-delivery devices required for this treatment. Miravant's product pipeline includes several therapeutic agents: PHOTREX, which is aimed at treating wet age-related macular degeneration (AMD); MV9411, a photoreactive compound developed for managing plaque psoriasis; MV0633, which targets conditions like atherosclerosis, vulnerable atherosclerotic plaque, and restenosis; MV2101, designed to address vascular access graft disease in hemodialysis patients; and MV6401, a treatment under development for solid tumors. The organization, originally established as PDT, Inc., officially adopted its current name, Miravant Medical Technologies Inc., in September of 1997. Founded in 1989, it maintains its corporate headquarters in Santa Barbara, California.
株価
$0.00001
最終同期: 2025-06-16
時価総額
$352.62
変化(1日)
-99.67%
変化(1年)
0.00%
US
取引 Miravant Medical Technologies Inc. (MRVT)

カテゴリー

Miravant Medical Technologies Inc.(MRVT)の株式分割履歴
Miravant Medical Technologies Inc.株(シンボル:MRVT)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 12, 2026に行われました。
Aug 12, 2026より前に購入されたMRVT株は、現在0MRVT株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割